Engaging Key Opinion Leaders (KOLs) and Healthcare Providers (HCPs) is important for achieving your strategic goal. Maximizing these engagements and building HCP relationships help you to deliver key messages within the industry. HCP contracting is a necessary process...
At every pharmaceutical company, the Medical Affairs (MA) team works to provide scientific and clinical support for their products. An MA team often shares important data about the product and disease state with physicians. Medical Science Liaisons (MSL) gather and...
In 2017, fewer than 20% of Key Opinion Leaders have a social media presence alongside their traditional medical education dissemination. Four years later, civilization is markedly different. The great wave of in-person to online transitions has carried medical opinion...
We recently had the opportunity to interview Michelle Warner, Global Medical Affairs Leader at GlaxoSmithKline. Michelle is a champion of being KOL-Centric, always keeping the team focused on the needs and interests of the KOL in their scientific relationships and...
Recently, several Medical Affairs organizations reached out with the same concern. Their Medical Directors wanted to improve their Key Opinion Leader (KOL) engagement outcomes but were not sure how to revise their engagement plans to make that happen. We’ll share the...
